NMT1 and breast carcinoma: While a very high proportion of breast cancer samples had detectable NMT1 protein levels (602 of 666 tumors), a large proportion (509 of 706 tumors) exhibited very low or undetectable amounts of NMT2 despite normal breast epithelia being ubiquitously positive for NMT2 proteins.